Pfizer, BioNTech say their Covid-19 vaccine is more than 90% effective
Pfizer and BioNTech SE are first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine09-11-2020
09-11-2020
Buy Pfizer; target of Rs 5890: ICICI Direct
ICICI Direct is bullish on Pfizer has recommended buy rating on the stock with a target price of Rs 5890 in its research report dated November 02, 2020.07-11-2020
COVID-19: UK vaccine chief hopes for positive Oxford and Pfizer data in early December
"If I put on my rose-tinted specs, I would hope that we will see positive interim data from both Oxford and from Pfizer/BioNTech in early December and if we get that then I think we have got the possibility of deploying by the year end," Kate Bingham, the chair of the UK Vaccine Taskforce, told lawmakers.04-11-2020
Pfizer Q2 net profit declines 15% at to 131.37 crore
The company had posted a net profit of Rs 154.25 crore for the corresponding period of the previous fiscal, Pfizer Ltd said in a filing to the BSE.02-11-2020
PFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed press release for the unaudited financial results for the quarter and half year ended September 30, 2020. Please take the above on record.02-11-2020
PFIZER LTD. - 500680 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2020
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the unaudited financial results for the quarter and half year ended September 30, 2020, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 11:45 a.m. and concluded at 1:45 p.m. Also please find enclosed the Limited Review Report by our Auditors M/s. Walker Chandiok & Co LLP, in respect of the above results. Please take the above on record.02-11-2020
Coronavirus vaccine update: Israel begins human trial, Moderna preps launch
Two coronavirus vaccine frontrunners - Pfizer and Moderna - are set to release late-stage and Phase-II results this month. Catch latest coronavirus vaccine updates here02-11-2020
Pfizer says COVID-19 vaccine still possible in 2020 despite data lag
Pfizer Chief Executive Albert Bourla said the drug giant could supply some 40 million doses in the United States in 2020 if clinical testing proceeds as expected and regulators approve a vaccine.28-10-2020
Qatar signs deal to buy Moderna COVID-19 vaccine
There are no internationally approved vaccines yet, but several are in advanced trials, including from Pfizer Inc, Johnson Johnson and Moderna.26-10-2020
Pfizer, J&J; urge clarity from FDA on future of Covid-19 vaccine trials once a vaccine is available
Once the first vaccines hit the market, volunteers may seek available vaccines instead of participating in ongoing trials; some may even withdraw23-10-2020